Abstract
Salvia divinorum is a medicinal and psychoactive plant endemic to the Sierra Madre Oriental of Oaxaca, Mexico. The Mazatec people have been using the leaves for centuries in ceremonies for its psychoactive properties and as a treatment for arthritis and inflammation, gastrointestinal problems, headaches, and addictions, among other uses. The active principle of Salvia divinorum, the terpene salvinorin A, is a uniquely potent and highly selective kappa-opioid receptor agonist and, as such, has enormous potential for the development of valuable medications. Among them, the most promising include safe and nonaddictive analgesics, neuroprotectors, short-acting anesthetics that do not depress respiration, antidepressants, anti-inflammatories, medications for the treatment of addiction to stimulants and alcohol, and drugs to treat disorders characterized by alterations in perception. The Mazatec consider Salvia divinorum to be a very powerful plant spirit that should be treated with utmost respect, and the preparation for the ceremony requires a strict regimen. They chew the fresh leaves at night while chanting and praying. In the Western use, the dry leaves are potentiated in extracts to be smoked. A lack of information about the appropriate doses and other considerations while smoking the extracts could result in overwhelming experiences due to the high potency and fast onset of the substance. For the Mazatec, smoking the plant is not the preferred mode. How could we create a bridge between the two perspectives? In this chapter, I will try to clarify the best ways to use Salvia divinorum for medicinal, psychotherapeutic, and inner exploration purposes.
Some say it is a sensual and tactile thing. Some say it’s about temporality and dimensionality, that it’s about time travel. Some say it’s about the Root Energy Network or that it’s about becoming a plant. This plant is the great secret of our tradition. Consciousness has to do with energy and light. It is really very simple; neither animals nor people have consciousness. It is plants that have consciousness: Animals get consciousness by eating plants
[Dale Pendell about Salvia divinorum, from his book Pharmako/Poeia (1995, p. 158)].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The Salvia divinorum Research and Information Center, sagewisdom.org
- 2.
A World Out of Mind, salviaspace.blogspot.com
- 3.
Center for Research and Ethnobotanical Conservation of Salvia divinorum, xkapastora.org
References
Aardvark, D. (Ed.) (2002). Salvia divinorum and salvinorin A. In The best of Entheogen Review 1992–2000 (2nd ed.). Sacramento, CA: Entheogen Review.
Addy, P. H. (2012). Acute and post-acute behavioral and psychological effects of salvinorin A in humans. Psychopharmacology, 220(1), 195–204.
Addy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. (2015). The subjective experience of acute, experimentally-induced Salvia divinorum inebriation. Journal of Psychopharmacology (Oxford), 29(4), 426–435.
Aviello, G., Borrelli, F., Guida, F., Romano, B., Lewellyn, K., De Chiaro, M., … Capasso, R. (2011). Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo. Journal of Molecular Medicine (Berlin), 89(9), 891–902.
Bücheler, R., Gleiter, C. H., Schwoerer, P., & Gaertner, I. (2005). Use of nonprohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner’s Sage). Pharmacopsychiatry, 38(1), 1–5.
Butelman, E. R., & Kreek, M. J. (2015). Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders. Frontiers in Pharmacology, 6, 190.
Carrera Guzmán, C. (2011). Acercamiento gramatical a la lengua mazateca de Mazatlán [Grammatical approach to the Mazateca language of Mazatlan]. Villa de Flores, Oaxaca, Mexico: INALI.
Casselman, I., Nock, C. J., Wohlmuth, H., Weatherby, R. P., & Heinrich, M. (2014). From local to global: Fifty years of research on Salvia divinorum. Journal of Ethnopharmacology, 151(2), 768–783.
Chavkin, C. (2013). Dynorphin – still an extraordinarily potent opioid peptide. Molecular Pharmacology, 83(4), 729–736.
Dos Santos, R. G., Crippa, J. A., Machado-de-Sousa, J. P., & Hallak, J. E. (2015). Salvinorin A and related compounds as therapeutic drugs for psychostimulant-related disorders. Current Drug Abuse Reviews, 7(2), 128–132.
Epling, C., & Játiva-M., C. D. (1962). A new species of Salvia from Mexico. Botanical Museum Leaflets, Harvard University, 20(3), 75–76.
Gómez Pompa, A. (1957). Salvia divinorum herbarium sheets. A. Gómez Pompa 87556 and 93216. Mexico, D.F: National Herbarium (UNAM).
Guida, F., Luongo, L., Aviello, G., Palazzo, E., De Chiaro, M., Gatta, L., … Maione, S. (2012). Salvinorin A reduces mechanical allodynia and spinal neuronal hyperexcitability induced by peripheral formalin injection. Molecular Pain, 8, 60.
Hanes, K. R. (2001). Antidepressant effects of the herb Salvia divinorum. Journal of Clinical Psychopharmacology, 21(6), 634–635.
Hanes, K. R. (2003). Salvia divinorum: Clinical and research potential. MAPS Bulletin, 13(1), 18–20.
Hanna, J. (1999). Growing Salvia divinorum from seed. The Entheogen Review, 8(3), 110–124.
Hofmann, A., & Tscherter, H. (1960). Isolation of lysergic acid alkaloids from the Mexican drug ololiuqui (Rivea corymbosa (L.) Hall.f.) Experientia, 16, 414.
Incháustegui, C. (1994). La mesa de plata: cosmogonÃa y curanderismo entre los mazatecos de Oaxaca [The silver table: Cosmogony and quackery among the Mazatecos of Oaxaca]. Oaxaca, Mexico: Instituto Oaxaqueño de las Culturas.
Jenks, A. A., Walker, J. B., & Kim, S. C. (2010). Evolution and origins of the Mazatec hallucinogenic sage, Salvia divinorum (Lamiaceae): A molecular phylogenetic approach. Journal of Plant Research, 124(5), 593–600.
Johnson, J. B. (1939). The elements of Mazatec witchcraft. Göteborgs Etnografiska Museum. Etnologiska Studier, 9, 119–149.
Kelly, B. C. (2011). Legally tripping: A qualitative profile of Salvia divinorum use among young adults. Journal of Psychoactive Drugs, 43, 46–54.
Luke, D. P., & Terhune, D. B. (2013). The induction of synaesthesia with chemical agents: A systematic review. Frontiers in Psychology, 4, 753. https://doi.org/10.3389/fpsyg.2013.00753
MacLean, K. A., Johnson, M. W., Reissig, C. J., Prisinzano, T. E., & Griffiths, R. R. (2013). Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic, and memory effects. Psychopharmacology, 226(2), 381–392.
Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., … Riba, J. (2015). Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans. International Journal of Neuropsychopharmacology, 18(12), pyv065. https://doi.org/10.1093/ijnp/pyv065
Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., … Riba, J. (2016). Naltrexone but not Ketanserin antagonizes the subjective, cardiovascular, and neuroendocrine effects of Salvinorin-A in humans. International Journal of Neuropsychopharmacology, 19(7), pyw016. https://doi.org/10.1093/ijnp/pyw016
McCurdy, C. R., Sufka, K. J., Smith, G. H., Warnick, J. E., & Nieto, M. J. (2006). Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacology, Biochemistry, and Behavior, 83(1), 109–113.
Nygård, E. A. (2007). Listening to the sage: The experience of learning from the Salvia divinorum altered state (Unpublished doctoral dissertation). Institute of Transpersonal Psychology, Palo Alto, CA.
Ortega, A., Blount, J. F., & Manchand, P. S. (1982). Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae). Journal of the Chemical Society, Perkin Transactions, 1(0), 2505–2508.
Orton, E., & Liu, R. (2014). Salvinorin A: A mini review of physical and chemical properties affecting its translation from research to clinical applications in humans. Translational Perioperative and Pain Medicine Journal, 1(1), 9–11.
Ott, J. (1995). Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A. Curare, 18(1), 103–129.
Raichle, M. E. (2011). The restless brain. Brain Connectivity, 1(1), 3–12.
Raichle, M. E., MacLeod, A. M., Snyder, A. Z., Powers, W. J., Gusnard, D. A., & Shulman, G. L. (2001). A default mode of brain function. Proceedings of the National Academy of Sciences of the United States of America, 98(2), 676–682.
Ranganathan, M., Schnakenberg, A., Skosnik, P. D., Cohen, B. M., Pittman, B., Sewell, R. A., & D’Souza, D. C. (2012). Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans. Biological Psychiatry, 72(10), 871–879.
Reisfield, A. S. (1993). The botany of Salvia divinorum (Labiatae). SIDA, 15(3), 349–366.
Reko, B. P. (1945). Mitobotanica Zapoteca. Tacubaya, Mexico: Private printing.
Rossi, A., Pace, S., Tedesco, F., Pagano, E., Guerra, G., Troisi, F., … Capasso, R. (2016). The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation. Pharmacological Research Journal, 106, 64–71.
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., … Rothman, R. B. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences of the United States of America, 99(18), 11934–11939.
Schmidt, M. D., Schmidt, M. S., Butelman, E. R., Harding, W. W., Tidgewell, K., Murry, D. J., … Prisinzano, T. E. (2005). Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates. Synapse, 58(3), 208–210.
Schwarzer, C. (2009). 30 years of dynorphins – new insights on their functions in neuropsychiatric diseases. Pharmacology & Therapeutics, 123(3), 353–370.
Serra, V., Fattore, L., Scherma, M., Collu, R., Spano, M. S., Fratta, W., & Fadda, P. (2015). Behavioral and neurochemical assessment of Salvinorin A abuse potential in the rat. Psychopharmacology, 232(1), 91–100.
Siebert, D. J. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43(1), 53–56.
Siebert, D. J. (1999). Clones of Salvia divinorum. Retrieved from http://www.lycaeum.org/salvia/clones.html
Siebert, D. J. (2003). The history of the first Salvia divinorum plants cultivated outside of Mexico. The Entheogen Review, 12(4), 117–118. Retrieved from http://www.sagewisdom.org/salviahistory.html
Siebert, D. J. (2004). Localization of salvinorin A and related compounds in glandular trichomes of the psychoactive sage, Salvia divinorum. Annals of Botany, 93(6), 763–777.
Soutar, I., & Strassman, R. (2000). Meditation with Salvia divinorum/Salvinorin A. Retrieved from http://www.maps.org/researcharchive/salvia/sdmeditation.html
Stiefel, K. M., Merrifield, A., & Holcombe, A. O. (2014). The claustrum’s proposed role in consciousness is supported by the effect and target localization of Salvia divinorum. Frontiers in Integrative Neuroscience, 8, 20.
Su, D., Riley, J., Kiessling, W. J., Armstead, W. M., & Liu, R. (2011). Salvinorin A produces cerebrovasodilation through activation of nitric oxide synthase, κ receptor, and adenosine triphosphate-sensitive potassium channel. Anesthesiology, 114(2), 374–379.
Taylor, G. T., & Manzella, F. (2016). Kappa opioids, Salvinorin A and major depressive disorder. Current Neuropharmacology Journal, 14(2), 165–176.
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2012). The dynorphin/kappa-opioid receptor system and its role in psychiatric disorders. Cellular and Molecular Life Sciences, 69(6), 857–896.
Valdes, J. L., III, Butler, W. M., Hatfield, G. M., Paul, A. G., & Koreeda, M. (1984). Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint Salvia divinorum. Journal of Organic Chemistry, 49, 4716–4720.
Valdes, J. L., III, Diaz, J. L., & Paul, A. G. (1983). Ethnopharmacology of ska Maria Pastora (Salvia divinorum Epling and Jativa-M). Journal of Ethnopharmacology, 7(3), 287–312.
Valdes, J. L., III, Hatfield, G. M., Koreeda, M., & Paul, A. G. (1987). Studies of Salvia divinorum (Lamiaceae), an hallucinogenic mint from the Sierra Mazateca in Oaxaca, Central Mexico. Economic Botany, 41(2), 283–291.
Vasiljevik, T., Groer, C. E., Lehner, K., Navarro, H., & Prisinzano, T. E. (2014). Studies toward the development of antiproliferative neoclerodanes from Salvinorin A. Journal of Natural Products, 77(8), 1817–1824.
Wasson, R. G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets Harvard University, 20(3), 77–84.
Weitlaner, R. J. (1952). Curaciones mazatecas [Mazatec cures]. Anales del Instituto Nacional de Antropologia e Historia, 4, 279–285.
Wu, H., Wacker, D., Katritch, V., Mileni, M., Han, G. W., Vardy, E., … Stevens, R. C. (2012). Structure of the human kappa opioid receptor in complex with JDTic. Nature, 485(7398), 327–332.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Maqueda, A.E. (2018). The Use of Salvia divinorum from a Mazatec Perspective. In: Labate, B., Cavnar, C. (eds) Plant Medicines, Healing and Psychedelic Science. Springer, Cham. https://doi.org/10.1007/978-3-319-76720-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-76720-8_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-76719-2
Online ISBN: 978-3-319-76720-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)